Immunophenotypic and genotypic characterization of progression in follicular lymphomas.
Progression of follicular lymphomas (FLs) is often accompanied by a spectrum of histologic changes and an aggressive clinical course. Although molecular alterations have been implicated in this event, the underlying factors are largely unknown. We studied the expression of selected tumor suppressor genes (P53 and retinoblastoma [RB]), oncogenes (MYC and BCL2), and a transferrin-receptor related protein (Trump) in sequential biopsies in 16 patients. Eleven patients progressed from grade I or II FL to aggressive B-cell lymphomas with diffuse morphology, whereas 5 patients presented with diffuse aggressive lymphomas and recurred with indolent lymphomas. Immunoreactivity for P53 correlated with higher histologic grade in lymphomas progressing from indolent to aggressive; however, only 1 patient who presented with aggressive lymphoma demonstrated a P53 gene mutation. Neither P53 immunoreactivity nor genotypic alterations correlated with presentation with an aggressive histology and relapse with FL. Growth fraction, as assessed by Ki-67 staining, and Trump expression correlated with histologic grade. Immunoreactivity for RB, BCL2, and MYC was seldom associated with progression. Eight of 9 cases tested exhibited identical immunoglobulin heavy and light chain rearrangements or identical BCL2 gene rearrangements in the sequential lymphomas. We conclude that P53 and Trump protein expression and proliferation activity correlate with histologic grade, but not with recurrence or progression of FL. Our results further indicate that progression of FL to diffuse aggressive lymphomas and presentation of an aggressive B-cell lymphoma followed by FL are clonally related.
Natkunam
Yasodha
Y
Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA. yaso@stanford.edu
Soslow
Robert
R
Matolcsy
Andras
A
Dolezal
Milana
M
Bhargava
Vivek
V
Knowles
Daniel M
DM
Warnke
Roger
R
D000951:Antigens, Neoplasm / Q000032:analysis* / Q000235:genetics; D001706:Biopsy; D019070:Cell Lineage; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D002999:Clone Cells / Q000473:pathology; D020732:Cytogenetic Analysis; D018450:Disease Progression; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D008224:Lymphoma, Follicular / Q000473:pathology*; D012189:Retrospective Studies; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D000951:Antigens, Neoplasm; D016159:Tumor Suppressor Protein p53